Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stephen D Hall

Showing results (31-40 of 133) with videos related to

Pageof 14
Sort By:
Drug Metabolism and Disposition: the Biological Fate of Chemicals|March 1, 2025
Improvement in static and dynamic projections of drug-drug interactions caused by cytochrome P4503A time-dependent inhibitors through in vitro allosteric modulation by progesteronePooja Hegde, Brianna Rodriguez, Alec Bell, et al.
Human Brain Mapping|November 26, 2009
Neuronal network pharmacodynamics of GABAergic modulation in the human cortex determined using pharmaco-magnetoencephalographyStephen D Hall, Gareth R Barnes, Paul L Furlong, et al.
Biochemical Pharmacology|April 20, 2006
Vincristine transcriptional regulation of efflux drug transporters in carcinoma cell linesRong Huang, Daryl J Murry, Dhanashri Kolwankar, et al.
Clinical Pharmacology and Therapeutics|June 28, 2002
Effect of St John's wort on the pharmacokinetics of fexofenadineZaiqi Wang, Mitchell A Hamman, Shiew-Mei Huang, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|January 10, 2012
Predictions of cytochrome P450-mediated drug-drug interactions using cryopreserved human hepatocytes: comparison of plasma and protein-free media incubation conditionsJialin Mao, Michael A Mohutsky, John P Harrelson, et al.
Brain Sciences|October 23, 2021
A Systematic Review of Neurofeedback for the Management of Motor Symptoms in Parkinson's DiseaseKrithika Anil, Stephen D Hall, Sara Demain, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|January 8, 2011
Prediction of CYP3A-mediated drug-drug interactions using human hepatocytes suspended in human plasmaJialin Mao, Michael A Mohutsky, John P Harrelson, et al.
Pharmaceutical Research|October 27, 2019
The Effect of Promiscuous Aggregation on in Vitro Drug Metabolism AssaysFrancesco Tres, Maria M Posada, Stephen D Hall, et al.
Scientific Reports|November 26, 2024
Characterising the anxiogenic network from functional connectivity analysis of the CO<sub>2</sub> challenge modelDaniel Graham, Santra Mathew, Jonathan Marsden, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|July 13, 2013
CYP2B6 pharmacogenetics-based in vitro-in vivo extrapolation of efavirenz clearance by physiologically based pharmacokinetic modelingCong Xu, Sara K Quinney, Yingying Guo, et al.
Pageof 14

Showing results (31-40 of 133) with videos related to

Sort By:
Pageof 14
Drug Metabolism and Disposition: the Biological Fate of Chemicals|March 1, 2025
Improvement in static and dynamic projections of drug-drug interactions caused by cytochrome P4503A time-dependent inhibitors through in vitro allosteric modulation by progesteronePooja Hegde, Brianna Rodriguez, Alec Bell, et al.
Human Brain Mapping|November 26, 2009
Neuronal network pharmacodynamics of GABAergic modulation in the human cortex determined using pharmaco-magnetoencephalographyStephen D Hall, Gareth R Barnes, Paul L Furlong, et al.
Biochemical Pharmacology|April 20, 2006
Vincristine transcriptional regulation of efflux drug transporters in carcinoma cell linesRong Huang, Daryl J Murry, Dhanashri Kolwankar, et al.
Clinical Pharmacology and Therapeutics|June 28, 2002
Effect of St John's wort on the pharmacokinetics of fexofenadineZaiqi Wang, Mitchell A Hamman, Shiew-Mei Huang, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|January 10, 2012
Predictions of cytochrome P450-mediated drug-drug interactions using cryopreserved human hepatocytes: comparison of plasma and protein-free media incubation conditionsJialin Mao, Michael A Mohutsky, John P Harrelson, et al.
Brain Sciences|October 23, 2021
A Systematic Review of Neurofeedback for the Management of Motor Symptoms in Parkinson's DiseaseKrithika Anil, Stephen D Hall, Sara Demain, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|January 8, 2011
Prediction of CYP3A-mediated drug-drug interactions using human hepatocytes suspended in human plasmaJialin Mao, Michael A Mohutsky, John P Harrelson, et al.
Pharmaceutical Research|October 27, 2019
The Effect of Promiscuous Aggregation on in Vitro Drug Metabolism AssaysFrancesco Tres, Maria M Posada, Stephen D Hall, et al.
Scientific Reports|November 26, 2024
Characterising the anxiogenic network from functional connectivity analysis of the CO<sub>2</sub> challenge modelDaniel Graham, Santra Mathew, Jonathan Marsden, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|July 13, 2013
CYP2B6 pharmacogenetics-based in vitro-in vivo extrapolation of efavirenz clearance by physiologically based pharmacokinetic modelingCong Xu, Sara K Quinney, Yingying Guo, et al.
Pageof 14